Targeted B-cell Depletion using Rituximab (Anti-CD20) in Recalcitrant Autoimmune Urticaria: Efficacy, Safety, and Mechanisms of Action

Targeted B-cell Depletion using Rituximab (Anti-CD20) in Recalcitrant Autoimmune Urticaria: Efficacy, Safety, and Mechanisms of Action

Anti-Fc[varepsilon]RIα and Anti-IgE, IgG and subclasses/IgA/IgM/IgE, C3/C4, CRP, basophil histamine release, B/T/NK numbers, basophil Fc[varepsilon]RIα and NK FcγRIII expression.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2008-02, Vol.121 (2), p.S172-S172
Hauptverfasser: Bingham, C.O, Jones, P.E, Gober, L.M, Eckman, J.A, Sterba, P.M, Saini, S.S
Format: Artikel
Sprache:eng
Schlagworte:
Allergies
Allergy and Immunology
Autoimmune diseases
Medical research
Patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Anti-Fc[varepsilon]RIα and Anti-IgE, IgG and subclasses/IgA/IgM/IgE, C3/C4, CRP, basophil histamine release, B/T/NK numbers, basophil Fc[varepsilon]RIα and NK FcγRIII expression.
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2007.12.634